Phase I trial of RDEA 3170 in healthy volunteers.

Trial Profile

Phase I trial of RDEA 3170 in healthy volunteers.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 07 Nov 2011

At a glance

  • Drugs Verinurad (Primary)
  • Indications Gout
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Nov 2011 Results presented at the 75th Annual Scientific Meeting of the American College of Rheumatology and the 46th Annual Meeting of the Association of Rheumatology Health Professionals, according to an Ardea Biosciences media release.
    • 07 Nov 2011 Status changed from not yet recruiting to recruiting.
    • 09 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top